Related Experiment Videos
Psychomotor, executive, and memory function in preclinical Huntington's disease
J S Snowden1, D Craufurd, J Thompson
1Department of Neurology, Manchester Royal Infirmary, UK. julie.snowden@man.ac.uk
Summary
Huntington's disease (HD) progression shows subtle psychomotor deficits years before symptoms appear, with memory decline accelerating near clinical onset. These findings clarify early HD changes.
Area of Science:
- Neuroscience
- Genetics
- Neurology
Background:
- The early developmental stages of Huntington's disease (HD) are not well understood.
- Previous studies on cognitive function in preclinical individuals with the HD mutation have produced conflicting results.
- Understanding these early changes is crucial for timely intervention and management of HD.
Purpose of the Study:
- To compare cognitive and motor performance in individuals with and without the HD mutation at various disease stages.
- To investigate the longitudinal evolution of cognitive and motor deficits in preclinical and early symptomatic HD.
- To resolve discrepancies in the literature regarding preclinical HD cognitive changes.
Main Methods:
- Comparative analysis of cognitive and motor performance.
- Inclusion of three groups: preclinical HD mutation carriers, at-risk non-carriers, and early-stage HD patients.
- Longitudinal assessment of psychomotor and memory tasks in relation to disease onset.
Main Results:
- Significant cognitive differences were observed between preclinical and early-stage HD groups.
- Individuals with the HD mutation but no clinical signs showed subtle psychomotor impairments compared to controls.
- Psychomotor deficits evolved gradually, while memory decline accelerated closer to clinical onset.
Conclusions:
- Functional deficits in Huntington's disease do not progress uniformly.
- Subtle psychomotor impairments can be detected in preclinical HD mutation carriers.
- Memory performance declines more rapidly around the time of clinical symptom manifestation.